Clal: Teva must greatly improve
Teva reported stable fourth quarter results for the US.
By KOBI YESHAYAHOU, GLOBES CORRESPONDENT
February 10, 2013 22:31
Optalgin pills Teva pharmaceuticals 390.
(photo credit: Teva Pharmaceuticals)
Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>